首页/数据集/Use and pharmaceutical expenditures for antihypertensive drugs by therapeutic class.

Use and pharmaceutical expenditures for antihypertensive drugs by therapeutic class.

NIAID Data Ecosystem2026-03-13 收录

数据链接：

https://figshare.com/articles/dataset/Use_and_pharmaceutical_expenditures_for_antihypertensive_drugs_by_therapeutic_class_/17208211 数据链接链接失效反馈

官方服务：

资源简介：

Use and pharmaceutical expenditures for antihypertensive drugs by therapeutic class.

应用场景：

创建时间：

2021-12-15

药物经济学

术后疼痛管理

These are peer-reviewed supplementary tables for the article ' Cost–effectiveness and cost-benefit analysis of oliceridine in the treatment of acute pain ' published in the Jo

DataCite Commons2026-04-29 更新180

Evaluation of drug utilisation pattern and cost associated with diabetes mellitusType 2 management in Saudi Arabia

糖尿病管理

药物经济学

Abstract Diabetic mellitus is an emerging disease in Saudi Arabia. In this regard, a cross-sectional retrospective study was conducted to evaluate drug utilization pattern and the cost associated with

DataCite Commons2023-01-07 更新50

Using Penalized Synthetic Controls on Truncated data: A Case Study on Effect of Marijuana Legalization on Direct Payments to Physicians by Opioid Manufacturers

公共卫生政策

药物经济学

Amid increasing awareness regarding opioid addiction, medical marijuana has emerged as a substitute to opioids for pain management. Concurrently, opioid manufacturers are putting significant research

Taylor & Francis Group2024-11-19 更新40

A cost-effectiveness analysis of second-generation antihistamine 1 receptor blockers and Japanese kampo shoseiryuto for treatment of perennial allergic rhinitis in outpatient settings in Japan

药物经济学

过敏性鼻炎治疗

Objectives: Perennial allergic rhinitis (PAR) is common in Japan. Second-generation antihistamines (SGAs) are commonly used for its treatment; however, it remains unclear which SGA is the most cost

DataCite Commons2025-04-01 更新60

Input parameters for the base-case analysis.

药物成本定价模型

药物经济学

Background Expanding the indication of already approved immuno-oncology drugs presents treatment opportunities for patients but also strains healthcare systems. Cost-based pricing models are discussed

NIAID Data Ecosystem50

Use and pharmaceutical expenditures for antihypertensive drugs by therapeutic class.

资源简介：

相关数据集